AMINOTHIAZOLVERBINDUNGEN ALS PROTEINKINASEHEMMER

European patent · EP3638237 · In force

Register entry

Publication number
EP3638237
Application number
EP18817380
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Jun 13, 2018
Published
Apr 22, 2020
Granted
Apr 19, 2023
Protection ends at the latest
Jun 12, 2038
Next annual fee due
Jun 30, 2027
IPC classes
A61K 31/4439 (2006.01)
A61K 31/496 (2006.01)
A61K 31/506 (2006.01)
C07D 417/14 (2006.01)
Priority
US 201762518855 P 13.06.2017
PCT application
PCT/US2018/037221 13.06.2018
PCT publication
WO2018/231910 20.12.2018
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Jul 1, 2026

    Next annual fee due on

    Next annual fee due on
    30.06.2026 → 30.06.2027

    Published in Swissreg on 01.07.2026

  2. Jul 1, 2025

    Next annual fee due on

    Next annual fee due on
    30.06.2025 → 30.06.2026

    Published in Swissreg on 01.07.2025

  3. Jul 4, 2024

    Change

    Published in Swissreg on 04.07.2024

  4. Feb 28, 2024

    Change

    Published in Swissreg on 28.02.2024

  5. Nov 30, 2023

    Change

    Published in Swissreg on 30.11.2023

  6. Apr 19, 2023

    Granted

    Published in Swissreg on 19.04.2023

Parties

Holder

National Health Research Institutes

No. 35, Keyan Road, Zhunan Town, Miaoli County 35053, TW

Inventor

TSAI, Hui-Jen

Kaohsiung City 804, TW

JIAANG, Weir-Torn

Songshan Dist. Taipei City 105, TW

SHIH, Chuan

Carmel, IN 46033, US

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.